12-methylcarnosic acid

Synopsis

12-Methylcarnosic Acid (12-O-Methylcarnosic Acid)

1. Identity, Nomenclature, and Chemical Nature

12-O-Methylcarnosic acid (also written as 12-methylcarnosic acid or 12-methoxycarnosic acid) is a naturally occurring phenolic diterpene belonging to the abietane-type diterpenoid class. It is structurally the 12-O-methyl ether derivative of carnosic acid — that is, carnosic acid with a methoxy (–OCH₃) group at the C-12 hydroxyl position in place of the free hydroxyl group present in the parent molecule.

Its systematic and common names include:

IUPAC / systematic name: 12-O-methylcarnosic acid
Synonyms: 12-methoxycarnosic acid; carnosic acid 12-methyl ether; methyl carnosate-12-methylether
CAS Registry Number: 62201-71-2
Molecular formula: C₂₁H₃₀O₄
Molecular weight: 346.47 g/mol
PubChem CID: 9974918 (12-O-Methylcarnosic acid)

12-O-Methylcarnosic acid is structurally related to a family of phenolic diterpenes that includes carnosic acid, carnosol, isorosmanol, rosmanol, and rosmanol-9-ethyl ether, all derived from the same abietane diterpene skeleton.

Synthetically, 12-O-methylcarnosic acid can be prepared through the methylation of carnosic acid, typically involving methanol and a strong acid catalyst under reflux conditions. However, the compound also occurs naturally and can be isolated directly from plant sources.

2. Natural Sources and Botanical Distribution

12-O-Methylcarnosic acid is a constituent of multiple aromatic plants within the family Lamiaceae (the mint family). Its primary natural sources are:

Rosemary (Rosmarinus officinalis L. / Salvia rosmarinus Spenn.)

The distribution of six compounds with three different polyphenol skeletons has been studied in Rosmarinus officinalis: phenolic diterpenes (carnosic acid, carnosol, and 12-O-methylcarnosic acid), caffeoyl derivatives (rosmarinic acid), and flavones (isoscutellarein 7-O-glucoside and genkwanin), each showing a characteristic behavior and distribution during the vegetative cycle. Only in leaves were all six compounds present, and the highest accumulation rate was related with the young stages of development. Carnosic acid and carnosol, along with 12-O-methylcarnosic acid, are found in their highest concentrations in photosynthetic tissues (i.e., leaves).

Sage Species

In continuation of studies on the chemical compositions of the aerial parts of cultivated Salvia officinalis L., 12-O-methylcarnosic acid (carnosic acid 12-methyl ether) was isolated for the first time in this type of sage. Additionally, 12-O-methylcarnosic acid has been widely detected in Rosmarinus officinalis, S. officinalis, and S. fruticosa.

Of particular note is Salvia pomifera (apple sage): carnosic acid and its metabolite carnosol were the most abundant terpene phenolic compounds of S. fruticosa, while they were completely absent in S. pomifera. The main terpene phenolic constituent of S. pomifera was 12-O-methylcarnosic acid.

Small-leaf sage and other Salvia species

12-O-Methylcarnosic acid is a diterpene carnosic acid isolated from the acetone extract of Salvia microphylla. It has also been identified from Salvia repens, where the compound was isolated and identified as the active antileishmanial component. A closely related compound, methyl carnosate-12-methylether, has also been isolated from Salvia tomentosa, a member of the genus Salvia (Lamiaceae), which is represented by 107 taxa in Turkish flora, with 58 being endemic, and is popularly used for medicinal purposes.

An NMR-based extraction optimization study confirmed 12-O-methylcarnosic acid (12MCA) as one of the principal bioactive abietane diterpenes found in infusions, decoctions, turbulent flow extracts, tinctures, and oleolites from three Salvia species: Salvia officinalis L. (common sage), Salvia fruticosa Mill. (Greek sage), and Salvia rosmarinus Spenn. (rosemary). Regarding the aqueous extracts, decoctions appeared to be richer sources of the studied metabolites than infusions among the three plants.

3. Traditional and Historical Use

12-O-Methylcarnosic acid as an isolated compound has no independent history of traditional use. It is instead a constituent of medicinal plants — most notably rosemary and sage — that have extensive documented use across multiple cultures and centuries. Its biological activities are therefore contextually linked to the traditional uses of these whole plant preparations.

Rosemary (Rosmarinus officinalis / Salvia rosmarinus)

Rosemary is native to the Mediterranean basin and has been used as both a culinary herb and medicinal plant in European, North African, and Middle Eastern traditions for over two millennia. Traditional uses have included digestive complaints, circulatory support, hair and scalp treatments, and as a preservative for food. The phenolic diterpene content — including carnosic acid and its derivatives such as 12-O-methylcarnosic acid — is chemically responsible for much of rosemary's antioxidant and preservative properties.

Sage (Salvia officinalis)

Common sage has a particularly long history of medicinal use in European folk medicine and is documented in classical texts dating to ancient Greece and Rome. Traditional preparations included herbal teas (infusions), decoctions, and tinctures for conditions including mouth and throat infections, digestive complaints, menopausal symptoms, and hyperglycemia. Carnosic acid was first discovered in Salvia officinalis L.

Salvia repens in Southern African Traditional Medicine

In South Africa, Salvia repens is used traditionally to treat sores, stomach ache, and diarrhoea. Scientific investigation of this traditional use led to the identification of 12-methoxycarnosic acid as the bioactive constituent with antiprotozoal activity in this plant.

4. Chemical Structure, Related Compounds, and Position Within the Diterpene Family

12-O-Methylcarnosic acid belongs to the abietane-type phenolic diterpene subclass within the broader diterpenoid natural product class. Its parent compound is carnosic acid, which is the main phenolic diterpene of rosemary (Rosmarinus officinalis L., Lamiaceae). The relationship between 12-O-methylcarnosic acid and other key Lamiaceae diterpenes is as follows:

Carnosic acid (CA): the parent compound of 12-O-methylcarnosic acid, known for its antioxidant properties.
Carnosol: another diterpene with similar antioxidant and anti-cancer activities.
Rosmanol: an oxidized derivative of carnosic acid with potent antioxidant activity.
12-O-Methylcarnosic acid: its methylated structure provides distinct chemical properties compared to its parent compound, carnosic acid.

The methylation at the C-12 position distinguishes this compound from carnosic acid. This structural modification means it does not undergo the same oxidative degradation pathway as carnosic acid (which is readily converted to carnosol via reactive oxygen species–mediated oxidation of the catechol moiety), because the free phenolic hydroxyl at C-12 — one of the two hydroxyls comprising the catechol unit in carnosic acid — is blocked as a methyl ether. Research suggests that while this compound is found in rosemary leaves, it is not involved in the same antioxidant mechanisms as its precursor, carnosic acid.

The compound's molecular formula (C₂₁H₃₀O₄) reflects the addition of one carbon and one oxygen relative to carnosic acid (C₂₀H₂₈O₄), consistent with the substitution of a methoxy group for a hydroxyl group.

5. Key Mechanisms of Action

5.1 Inhibition of 5α-Reductase

12-O-Methylcarnosic acid (12-methoxycarnosic acid) is an active constituent of 5α-reductase inhibition with an IC₅₀ value of 61.7 μM. 5α-Reductase is the enzyme that converts testosterone to dihydrotestosterone (DHT); inhibition of this enzyme is the principle mechanism exploited by pharmaceutical agents such as finasteride for the treatment of androgenetic alopecia and benign prostatic hyperplasia.

The whole rosemary extract (RO-ext) showed inhibitory activity of 82.4% and 94.6% at 200 and 500 µg/mL, respectively. As an active constituent of 5α-reductase inhibition, 12-methoxycarnosic acid was identified with activity-guided fractionation.

5.2 Androgen Receptor Pathway Modulation

The extract of R. officinalis and 12-methoxycarnosic acid inhibited androgen-dependent proliferation of LNCaP cells as 64.5% and 66.7% at 5 µg/mL and 5 μM, respectively. These results suggest that they inhibit the binding of dihydrotestosterone to androgen receptors.

12-O-Methylcarnosic acid inhibits proliferation in LNCaP cells — an androgen-dependent prostate cancer cell line, providing the primary cellular evidence for androgen receptor–mediated activity.

5.3 PPARγ Activation

12-O-Methyl carnosic acid and alpha-linolenic acid were able to significantly activate PPARγ, whereas the remaining metabolites from Salvia officinalis were either unable to activate PPARγ or yielded insignificant activation. Selected metabolites from Salvia officinalis were able to activate PPARγ and hence, the anti-diabetic activity of this plant could in part be mediated through this nuclear receptor. PPARγ (peroxisome proliferator-activated receptor gamma) is a nuclear receptor that plays a central role in adipogenesis, glucose homeostasis, and insulin sensitization.

5.4 Antioxidant Activity

12-O-Methylcarnosic acid has antioxidant activity. Significant and moderate Pearson's correlations were obtained for the antioxidant activity measured using FRAP and DPPH assays of this diterpene. Its antioxidant mechanism differs from that of the parent compound carnosic acid, since the methyl ether at C-12 blocks the catechol moiety that would ordinarily enable radical quenching via hydrogen atom transfer.

5.5 Melanin Suppression via Tyrosinase Downregulation

12-O-Methylcarnosic acid can suppress melanin production with downregulation of tyrosinase expression in HMV-II melanoma cells. Tyrosinase is the key rate-limiting enzyme in melanin biosynthesis, and its downregulation reduces pigmentation — a mechanism explored in the context of hyperpigmentation disorders and skin lightening research.

5.6 Gastroprotective Activity

The naturally occurring 12-O-methylcarnosic acid was included in a study evaluating gastroprotective activity in the HCl/EtOH-induced gastric lesions model in mice, and for cytotoxicity in human adenocarcinoma AGS cells, Hep G2 hepatocellular carcinoma cells, and human lung fibroblasts. At 10 mg/kg, 12-O-methylcarnosic acid (compound 14) was more effective in preventing gastric lesions than the reference compound lansoprazole at the same dose.

5.7 Antiprotozoal Activity

HPLC-based activity profiling of S. repens whole plant extract showed an active abietane diterpene, identified as 12-methoxycarnosic acid, which showed antiprotozoal activity against axenically grown Leishmania donovani amastigotes with an IC₅₀ of 0.75 μM with marginal cytotoxicity against the L6-cells (IC₅₀, 17.3 μM).

5.8 Antimicrobial Activity

Selected compounds from Salvia microphylla were tested for antimicrobial activity against standard bacterial strains, and only carnosic acid 12-methyl ether showed antimicrobial activity against S. aureus at 78 µg/mL.

6. Scientific Evidence by Area of Use

6.1 Hair Growth and Androgenetic Alopecia

This is the area with the most direct and extensively studied experimental evidence involving 12-O-methylcarnosic acid as an identified active compound.

Key study (Murata et al., 2013, Phytotherapy Research, PMID 22517595): Topical administration of Rosmarinus officinalis leaf extract (RO-ext, 2 mg/day/mouse) improved hair regrowth in C57BL/6NCrSlc mice that experienced hair regrowth interruption induced by testosterone treatment. In addition, RO-ext promoted hair growth in C3H/He mice that had their dorsal areas shaved. To investigate the antiandrogenic activity mechanism of RO-ext, the researchers focused on inhibition of testosterone 5α-reductase; RO-ext showed inhibitory activity of 82.4% and 94.6% at 200 and 500 µg/mL, respectively. As an active constituent of 5α-reductase inhibition, 12-methoxycarnosic acid was identified with activity-guided fractionation. In addition, the extract of R. officinalis and 12-methoxycarnosic acid inhibited androgen-dependent proliferation of LNCaP cells as 64.5% and 66.7% at 5 µg/mL and 5 μM, respectively.

Rosemary leaf extracts were found to promote hair growth in mice when applied topically at a dose of 2 mg per day; moreover, an increase in the expression of insulin-like growth factor-1 and vascular endothelial growth factor were noted after application, both of which are important factors in hair growth.

Evidence strength: The evidence for 12-O-methylcarnosic acid specifically in hair growth is preclinical (in vitro enzyme inhibition and in vivo rodent models). The compound was identified by activity-guided fractionation as the key 5α-reductase inhibitor in rosemary extract. No clinical trials have directly tested the isolated compound; human evidence for rosemary extract in hair growth exists separately (Panahi et al., 2015), but does not isolate the contribution of 12-O-methylcarnosic acid specifically. The mechanistic evidence at the enzyme and cellular level is robust, but translation to human dosing of the isolated compound remains unestablished.

6.2 Antiprotozoal / Antileishmanial Activity

Study (Mokoka et al., 2014, South African Journal of Botany, doi: 10.1016/j.sajb.2013.10.014): The active antileishmanial component of Salvia repens was isolated and identified to be 12-methoxycarnosic acid. The HPLC-based activity profiling of S. repens whole plant extract showed an active abietane diterpene, identified as 12-methoxycarnosic acid, which showed antiprotozoal activity against axenically grown Leishmania donovani amastigotes with an IC₅₀ of 0.75 μM with marginal cytotoxicity against the L6-cells (IC₅₀, 17.3 μM). The high selectivity index (ratio of cytotoxic IC₅₀ to antiparasitic IC₅₀ ≈ 23) suggests a meaningful therapeutic window in vitro.

Evidence strength: Preliminary — in vitro only. No animal or human studies have been conducted with 12-O-methylcarnosic acid specifically for leishmaniasis. The result is of interest for drug discovery but does not constitute evidence for clinical efficacy or safety in this indication.

6.3 Anticancer / Antiproliferative Activity

Study (Salvia pomifera and Salvia fruticosa extracts, PMC6720736, Molecules 2019): The phenolic compounds of methanolic extracts of Salvia pomifera and Salvia fruticosa were identified by liquid chromatography tandem mass spectrometry. Carnosic acid and its metabolite carnosol were the most abundant terpene phenolic compounds of S. fruticosa, while they were completely absent in S. pomifera. The main terpene phenolic constituent of S. pomifera was 12-O-methylcarnosic acid. The effects of Salvia extracts and/or carnosic acid on the proliferation and cell cycle of two melanoma cell lines (A375, Mel JuSo) and human fibroblast cell line (HFF) were investigated by MTT assay, PI-exclusion assay and flow cytometry cell cycle analysis. Extract of S. fruticosa more efficiently than S. pomifera extract reduced the proliferation of the human melanoma cells. The study identified carnosic acid (predominant in S. fruticosa) as the more potent compound, while the 12-O-methylcarnosic acid–rich S. pomifera extract showed weaker antiproliferative effects.

Study (Salvia tomentosa, Revista Brasileira de Farmacognosia, 2025): This study investigated the effects of S. tomentosa Mill. extracts with different polarities on the proliferation rate, apoptotic death levels and migration rates of MCF-7, UPCI-SCC-131, Huh-7 cancer cells, as well as healthy A7r5 cells. An abietane-type diterpene derivative, methyl carnosate-12-methylether, was isolated from the extract and IC₅₀ values were detected as 12.77, 21.21, 10.27 and 12.16 μM against MCF-7, UPCI-SCC-131, Huh-7 and A7r5 cell lines, respectively. Notably, the IC₅₀ value against the healthy A7r5 cell line (12.16 μM) was similar to those for the cancer cell lines, indicating limited selectivity for cancer cells over normal cells in this study.

LNCaP cells (prostate cancer): 12-O-Methylcarnosic acid (5 μM) inhibits androgen-dependent proliferation of LNCaP cells by 66.7%.

Evidence strength: Entirely preclinical (in vitro cell line experiments). No animal tumor models or human clinical data exist for 12-O-methylcarnosic acid in cancer. Activity has been documented in melanoma, breast, hepatocellular, and prostate cancer cell lines, but the evidence base is exploratory.

6.4 Anti-Diabetic / Metabolic Activity

Eight diterpenes were isolated and identified from Salvia officinalis, including 12-O-methyl carnosic acid, and it was one of only two compounds able to significantly activate PPARγ, whereas the remaining metabolites were either unable to activate PPARγ or yielded insignificant activation. Selected metabolites from Salvia officinalis were able to activate PPARγ and hence, the anti-diabetic activity of this plant could in part be mediated through this nuclear receptor.

12-O-Methylcarnosic acid may have anti-diabetic activity; it is able to significantly activate peroxisome proliferator-activated receptor (PPAR)γ.

Evidence strength: Preliminary — in vitro receptor activation data only. The PPARγ activation study is a mechanistic in vitro finding from isolated Salvia officinalis constituents. No animal models or human trials have been conducted using isolated 12-O-methylcarnosic acid for diabetes or metabolic endpoints.

6.5 Gastroprotective Activity

The naturally occurring 12-O-methylcarnosic acid was included in a study evaluating gastroprotective activity in the HCl/EtOH-induced gastric lesions model in mice, and for cytotoxicity in human adenocarcinoma AGS cells, HepG2 hepatocellular carcinoma cells, and human lung fibroblasts. At 10 mg/kg, 12-O-methylcarnosic acid was among the CA derivatives more effective in preventing gastric lesions than the reference compound lansoprazole at the same dose.

Evidence strength: Preclinical — single in vivo mouse model and in vitro cytotoxicity screens. No human gastroprotection trials have been conducted with the isolated compound.

6.6 Antimicrobial Activity

From the acetone extract of Salvia microphylla, compounds including a diterpene carnosic acid 12-methyl ether (12-methoxycarnosic acid) were isolated along with sesquiterpenes and triterpenes. The selected compounds were tested for antimicrobial activity against standard bacterial strains, and only carnosic acid 12-methyl ether showed antimicrobial activity against S. aureus at 78 µg/mL. This minimum inhibitory concentration (MIC) value was established in vitro.

Evidence strength: Preliminary in vitro data. Activity against a single organism (S. aureus) at a defined MIC. No further antimicrobial studies or clinical work on isolated 12-O-methylcarnosic acid have been identified.

6.7 Skin / Melanin Suppression

12-O-Methylcarnosic acid can suppress melanin production with downregulation of tyrosinase expression in HMV-II melanoma cells. This in vitro finding suggests potential relevance to hyperpigmentation. No clinical evidence is available for this indication with the isolated compound.

7. Pharmacokinetics in Humans

A significant 2023 human pharmacokinetic study (Huang et al., Molecular Nutrition & Food Research, PMID 37310415) characterized the absorption and plasma profile of 12-methoxycarnosic acid following dietary consumption in humans.

Study design: Plasma samples from a randomized, single-blinded, 4-arm, 24-hour, crossover clinical trial (ClinicalTrials.gov NCT03926442) were used. Subjects (n = 24, aged 37 ± 3 years, BMI = 28.4 ± 0.6 kg/m²) consumed a high-fat/high-carbohydrate meal with salt and pepper only (control) or with three different herb/spice mixtures: Italian herbs (rosemary, basil, thyme, oregano, and parsley), cinnamon, and pumpkin pie spice, and blood samples were collected at 0, 0.5, 1, 2, 4, 5.5, 7 and 24 hours.

Key finding for 12-methoxycarnosic acid: Carnosic acid and its derivatives (12-methoxycarnosic acid, carnosol, and their conjugated glucuronides) were the major terpenoid compounds that increased after consumption of the Italian herb meal. After consuming the Italian herbs meal, carnosol appeared in plasma early, peaking at 1 hour (48.2 ± 7.0 nmol/L); carnosic acid and 12-methoxycarnosic acid peaked at 2 hours (366.4 ± 142.2 nmol/L and 588.6 ± 66.3 nmol/L, respectively), and these metabolites circulated in the body for up to 24 hours.

12-methoxycarnosic acid and its conjugated glucuronide had a significantly different AUC₀–₂₄ₕ after intake of Italian herb meal compared to AUC₀–₂₄ₕ of these compounds after intake of the control meal (both p < 0.0001).

This is the only published human pharmacokinetic data for 12-O-methylcarnosic acid. The findings confirm that the compound is absorbed from dietary herb sources and reaches measurable plasma concentrations following a single meal. Plasma levels peaked at 588.6 ± 66.3 nmol/L and the compound circulated for at least 24 hours. The detection of glucuronide conjugates indicates that phase II metabolic conjugation occurs in vivo. It should be noted that these findings derive from an Italian herb blend (not isolated 12-O-methylcarnosic acid), so the precise dose of the compound consumed was not stated separately in the available data.

8. Body Systems and Health Areas Associated with 12-O-Methylcarnosic Acid

Integumentary system (hair and skin): 5α-reductase inhibition relevant to androgenetic alopecia; DHT–androgen receptor blockade; melanin suppression via tyrosinase downregulation.
Endocrine / metabolic system: PPARγ activation linking it to glucose metabolism and insulin signaling.
Gastrointestinal system: gastroprotective activity in animal ulcer models.
Immune / infectious disease: antileishmanial activity (in vitro); antimicrobial activity against S. aureus (in vitro).
Oncology (experimental only): antiproliferative activity demonstrated in melanoma, prostate, breast, and hepatocellular carcinoma cell lines in vitro.

9. Dosage Forms and Concentrations Reported in Studies

No clinical dosing recommendations exist for isolated 12-O-methylcarnosic acid as a standalone supplement, as the compound has not been the subject of human clinical trials in isolation. The following are the doses and concentrations reported in specific research contexts:

5α-Reductase inhibition (IC₅₀): 61.7 μM in enzyme inhibition assays.
LNCaP cell proliferation inhibition: 5 μM resulted in 66.7% inhibition of androgen-dependent proliferation.
Topical rosemary extract (hair growth, mouse model): 2 mg/day/mouse of R. officinalis leaf extract (containing 12-methoxycarnosic acid) administered topically improved hair regrowth in C57BL/6NCrSlc mice.
Whole extract 5α-reductase inhibition: 82.4% inhibition at 200 µg/mL and 94.6% inhibition at 500 µg/mL for the whole rosemary extract.
Gastroprotection (mouse model): At 10 mg/kg (including 12-O-methylcarnosic acid), the derivative was more effective than lansoprazole at the same dose in the HCl/EtOH-induced gastric lesions model.
Antileishmanial (in vitro): IC₅₀ of 0.75 μM against L. donovani amastigotes; marginal cytotoxicity against L6-cells (IC₅₀ 17.3 μM).
Antimicrobial (in vitro): Antimicrobial activity against S. aureus at 78 µg/mL.
Anticancer (Salvia tomentosa, in vitro): IC₅₀ values of 12.77, 21.21, 10.27, and 12.16 μM against MCF-7, UPCI-SCC-131, Huh-7, and A7r5 cell lines, respectively.
Human plasma (dietary exposure): 12-methoxycarnosic acid peaked at 2 hours at a plasma concentration of 588.6 ± 66.3 nmol/L after consumption of an Italian herb meal.

In commercial analytical reference standard preparations, 12-O-methylcarnosic acid is typically provided at ≥95–99% purity confirmed by HPLC-DAD and identified by mass spectrometry and NMR. These are research-grade standards, not supplement formulations.

10. Safety Considerations

No dedicated human safety, toxicology, or pharmacovigilance studies have been conducted specifically for isolated 12-O-methylcarnosic acid. The following safety-relevant data points are derived directly from published research:

10.1 Cytotoxicity Toward Normal Cells

In the Salvia tomentosa cytotoxicity study, methyl carnosate-12-methylether showed an IC₅₀ of 12.16 μM against the healthy A7r5 smooth muscle cell line — a value comparable to those observed for cancer cell lines in the same study (10.27–21.21 μM), indicating limited cancer cell selectivity under these in vitro conditions.

In the antileishmanial study, the compound showed marginal cytotoxicity against L6-cells (IC₅₀ 17.3 μM), with an antiprotozoal IC₅₀ of 0.75 μM, representing a selectivity index of approximately 23-fold — a more favorable cytotoxicity profile in that context.

10.2 Commercial Research Reagent Status

All major suppliers of 12-O-methylcarnosic acid classify it explicitly as a research chemical. As stated by multiple suppliers, the compound is for research use only and is not sold to patients. It does not hold approved dietary supplement, drug, or food additive status as an isolated compound in major regulatory jurisdictions, to the extent documented in the available scientific literature.

10.3 Parent Compound Safety Context

The safety of carnosic acid and related rosemary phenolic diterpenes has been evaluated by regulatory bodies. The European Food Safety Authority (EFSA) has assessed rosemary extract (E392) as a food additive. However, these evaluations pertain to extracts standardized for carnosic acid and carnosol content and do not directly address 12-O-methylcarnosic acid.

10.4 Drug Interactions

No specific drug interaction data exist for isolated 12-O-methylcarnosic acid. Given its identified inhibitory activity against 5α-reductase, potential additive effects with pharmaceutical 5α-reductase inhibitors (finasteride, dutasteride) are a theoretically relevant consideration, but this has not been experimentally investigated. PPARγ activation could theoretically interact with thiazolidinedione-class antidiabetic medications, but again no data are available for the isolated compound.

10.5 Absence of Human Clinical Safety Data

To date, no clinical trials, observational studies, case series, or pharmacovigilance reports specifically addressing the safety of isolated 12-O-methylcarnosic acid in humans have been identified in the peer-reviewed literature. The human pharmacokinetic evidence (Huang et al., 2023) documents plasma exposure following dietary consumption of herbs but does not report adverse events attributable to this compound specifically.

11. Summary of Evidence Status

12-O-Methylcarnosic acid is a structurally well-characterized phenolic diterpene with a defined CAS number, molecular formula, and multiple published isolation reports from Lamiaceae species including rosemary, sage, and several Salvia species. Its most thoroughly documented biological activity is inhibition of 5α-reductase, identified by activity-guided fractionation from rosemary extract, with in vitro and animal-model support. PPARγ activation, antileishmanial activity, gastroprotection, anti-melanogenic activity, and antimicrobial activity represent additional mechanistic findings at the in vitro or animal level. The compound reaches measurable plasma concentrations in humans following dietary herb consumption, confirming oral bioavailability. However, it has not been the subject of any published randomized controlled trial, clinical pilot study, or systematic review as an isolated agent, and no approved dosing regimen exists for any indication.